Wnt signaling is recognized to be dysfunctional in AD, and stimulation of the Wnt/β-catenin signaling pathway inhibits β-secretase (BACE-1) expression, inhibits Aβ production, and tau hyperphosphorylation in the brain [51]. This evidence concerns the gene MAPT and Alzheimer disease.